ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sienna slumps as acne asset flunks phase 3 trials
fiercebiotech
July 31, 2018Sienna Biopharmaceuticals’ acne candidate SNA-001 has comprehensively?failed?two phase 3 trials. The addition of the silver particle treatment to laser light therapy failed to improve outcomes against three key endpoints.....
Pharma Sources Insight January 2025
